The Prevalence of Autoantibodies in Complex Regional Pain Syndrome Type I
Autoimmunity has been suggested as one of the pathophysiologic mechanisms that may underlie complex regional pain syndrome (CRPS). Screening for antinuclear antibodies (ANA) is one of the diagnostic tests, which is usually performed if a person is suspected to have a systemic autoimmune disease. Ant...
Saved in:
Main Authors: | Maaike Dirckx, Marco W. J. Schreurs, Marissa de Mos, Dirk L. Stronks, Frank J. P. M. Huygen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2015/718201 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elevated Plasma Levels of sIL-2R in Complex Regional Pain Syndrome: A Pathogenic Role for T-Lymphocytes?
by: Krishna D. Bharwani, et al.
Published: (2017-01-01) -
Serum Soluble Interleukin-2 Receptor Does Not Differentiate Complex Regional Pain Syndrome from Other Pain Conditions in a Tertiary Referral Setting
by: K. D. Bharwani, et al.
Published: (2020-01-01) -
Evidence for local inflammation in complex regional pain syndrome type 1
by: Frank J. P. M. Huygen, et al.
Published: (2002-01-01) -
Intermediate Stage Complex Regional Pain Syndrome Type 1 Is Unrelated to Proinflammatory Cytokines
by: Renate J. M. Munnikes, et al.
Published: (2005-01-01) -
Expression of Endothelial Nitric Oxide Synthase and Endothelin-1 in Skin Tissue from Amputated Limbs of Patients with Complex Regional Pain Syndrome
by: J. George Groeneweg, et al.
Published: (2008-01-01)